SCHOTT Pharma AG & Co. KGaA (1SXP.DE) research: valuation against peers, fundamentals over time, risk and news coverage
1SXP.DE
SCHOTT Pharma AG & Co. KGaANo data in this window.
Every report in our own archive tagged with this symbol, newest first — fetched from the archive alongside the market data.
- SPECIAL REPORTNEUTRALNordic and European Reporting Season Splinters: Volume Records Meet Organic Growth Stalls
Q2 2026 European results reveal a widening dispersion between volume-driven earnings growth and companies relying on cost discipline, with the market rewarding structural demand and penalizing stalled top-lines.
- SPECIAL REPORTBEARISHEuropean Equities Drift Lower as Oil's Six-Day Rally Collides With U.S. Inflation Risk
European bourses edged lower as a six-session advance in crude oil and looming U.S. inflation data kept risk appetite in check. The soft index tone masked a bifurcated earnings season, with guidance raises at Balfour Beatty, Bechtle and Schott Pharma offset by profit warnings and rate-driven pressure elsewhere.
Every figure on this page is fetched and computed in your browser from free public sources — end-of-day prices and reported financials from Yahoo Finance's open endpoints, and our own archive for the coverage panel. Fundamental history on the free tier runs about four fiscal years and five quarters. Data is best-effort and unaudited; this is market research, not investment advice.